The expression of Braf V600E in murine HSC resulted in a lethal disorder reminiscent of HCL, characterized by increased self-renewal capacity of early B lineage cells and impairment of myeloid and erythroid differentiation; the use of a BRAF inhibitor reversed the phenotype. Here, BRAF is linked to hairy cell leukemia.